About Xbiotech (XBIT)
XBiotech Inc. is a clinical-stage biopharmaceutical company. The Company discovers and develops monoclonal antibodies for treating a variety of diseases, such as cancer, vascular disease, inflammatory skin disease, and diabetes.
- USD2.89
- USD2.98
- USD2.75
- USD9.05
- -17.60%
- --
- 43.04k
- 62.15k
- 89M
- 2.65
- -67.80%
Stock News
yesterday
Ras Baraka arrest: Trump administration eyes charging three more NJ Democrats in ICE fracas
CNBC
yesterday
Warner Music Group Corp. (WMG) Q2 2025 Earnings Call Transcript
SeekingAlpha
yesterday
The case for owning stocks at every age, plus what the Street means by 'risk off'
CNBC
yesterday
I pay $4,000 a month for rent in Manhattan. Should I be paying for a mortgage instead?
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
